Chargement en cours...
Management of severe COPD exacerbations: focus on beclomethasone dipropionate/formoterol/glycopyrronium bromide
The major determinant of the decline in lung function, quality of life, and the increased mortality risk in patients with COPD is represented by severe acute exacerbations of the disease, that is, those requiring patients’ hospitalization, constituting a substantial social and health care burden in...
Enregistré dans:
| Publié dans: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6072677/ https://ncbi.nlm.nih.gov/pubmed/30104872 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S147484 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|